At-Home Hematology Testing Market Gaining Pace Amid Increasing Focus on Point-of-Care Diagnostics
At-Home Hematology Testing Market Gaining Pace Amid Increasing Focus on Point-of-Care Diagnostics
The At-home hematology testing market survey analyzes factors affecting growth trajectory across key segments, including types and processing method. It also studies the impact of strategies adopted by vendors such as introducing technological improvements to facilitate at-home hematology testing.
Fact.MR – A Market Research and Competitive Intelligence Provider: According to a study by Fact.MR, the global at-home hematology testing market is expected to register a growth at 5.5% CAGR between 2021 and 2031. Sales will increase in response to the rising emphasis on advanced home healthcare solutions.
The market gained immense momentum amid COVID-19 outbreak as people exhibited greater inclination for reducing visits to labs for blood tests. Coupled with this, the rising prevalence of cholesterol, oncological disorders, blood-related disorders, and heart diseases will create scope for at-home hematology testing kits sales.
It has become a common practice among patients of lifestyle diseases to monitor their health to prevent any unforeseen medical emergency. At-home hematology testing kits are considered ideal for such patients.
Development of technologically advanced hematology analyzers and high-sensitivity point-of-care and the increasing usage of flow cytometry in hematology testing are expected to create attractive growth prospects for the market.
As developed nations are gradually inching towards maturity, market players are shifting their focus towards more lucrative pockets in China, Mexico, India, and Brazil. Growing patient population, investment in healthcare infrastructure, and rising popularity of medical tourism will present attractive opportunities to capitalize in these countries.
Nonetheless, the U.S. at-home testing market will continue witnessing steady growth through the forecast period. Increasing cases of blood disorders such as thalassemia and awareness about the same will give tailwinds to at-home testing adoption in the country. Also, the introduction of advanced technologies for POC test, favorable reimbursement policies, and constantly increasing geriatric population will aid overall expansion.
“Leading players are investing in research and development activities to launch novel, safe, and effective at-home hematology testing products that will cater rising need for in-vitro diagnostic tests,” says Fact.MR analyst.
Request Sample Here For More Information on How to Improve Your At-Home Hematology Testing Market Footprint
https://www.factmr.com/connectus/sample?flag=S&rep_id=6486
Key Takeaways from At-home Hematology Testing Market Survey
- Germany is expected to lead the Europe market as the country records increasing cases anaemia.
- The U.S. is expected to lead the global market as the country has advanced healthcare infrastructure. Besides this, government sponsorship and rising geriatric population will guarantee growth in the coming years.
- Canada will witness rising sales of at-home hematology testing market following the rising awareness about blood disorders and presence of key players who are developing cost-effective and at home hematology products.
- Home hematology testing is primarily undertaken to monitor the complete blood count. This will also remain the preferred test type in the market.
Key Drivers
- Rising cases of blood cancer and consequent demand for advanced solutions to monitor the health of patients at home will create opportunities for growth.
- Government initiatives undertaken to reduce healthcare burden are propelling sales for at-home hematology testing market in the global market.
- Automation is an important focus area for hematology labs for pre-analytical, analytical, and post-analytic steps to improve efficiency and standardize the process. Rising focus on automation and consequent launch of novel technologies will aid overall expansion of the market.
Key Restrains
- At-home hematology testing devices needs to go through numerous trails to ascertain quality standards. This often slows down the production process and hinders market growth.
- Expensive production cost and difficult in availability of devices in remote areas across the globe will hamper the global sales of at-home hematology testing market.
Ask an Analyst Here If You Want To Learn More about the Regional Landscape of the At-Home Hematology Testing Market
https://www.factmr.com/connectus/sample?flag=AE&rep_id=6486
Competitive Landscape
The global at-home hematology testing market is highly fragmented due to the presence of numerous global and regional manufacturers. The players are focusing on research and development activities to launch safe and efficient at-home hematology testing devices to cater rising needs of in-vitro diagnostic tests.
Some of the key players operating in the global at-home hematology testing market as profiled by Fact.MR are:
- Siemens Healthineers
- F. Hoffmann-La Roche Ltd.
- Mindray Medical International Limited
- Sysmex Corp
- Abbott Laboratories
- Horiba Ltd.
- Danaher Corp
- EKF Diagnostics Holdings Plc
- OmegaQuant
- LLC
- Sysmex Corporation.
More Valuable Insights on At-home Hematology Testing Market
Fact.MR, in its new report, offers an unbiased analysis of the global at-home hematology testing market, analyzing forecast statistics through 2021 and beyond. The survey reveals growth projections on in at-home hematology testing market with detailed segmentation:
By Test Type
- Complete Blood Count
- Platelet Function
- Hemoglobin
- Hematocrit
By Indication
- Diabetes
- Anaemia
- Bacterial and viral infections
- Cancer
- Heart Disease
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa
Key Questions Covered in the At-Home Hematology Testing Market Report
- The market survey also highlights projected sales growth for at-home hematology testing market between 2021 and 2031
- The report offers insight into at-home hematology testing demand outlook for 2021-2031
- At-home hematology testing market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, collaborations or partnerships, and others
- At-home hematology testing market analysis identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry
Explore Fact.MR’s Coverage on the Healthcare Domain
Home Diagnostics Market - The United States of America held the largest share of the home diagnostics market in North America, accounting for over 40% of market revenue, and is likely to continue this position during the forecast period. The United Kingdom, France, and Germany are among the European countries with the highest penetration of home diagnostics. Because home diagnostics makes it easier for people all over the world to keep track of their health, demand for these kits is increasing.
Diabetes Diagnostics Market - In a recent analysis, Fact.MR predicted that hospital demand would continue to rise over the prediction period of 2020 to 2030. Government investment for hospitals will help to expand the market overall by making healthcare more accessible in remote areas. Through 2030, the global diabetes diagnostics market will be dominated by players from North America, Asia Pacific, and Europe. The global diabetes diagnostics market is growing at a rapid pace, owing to the rising prevalence of diabetes.
Hemoglobin Testing Systems Market - The market for hemoglobin testing systems is expected to develop due to the rising frequency of blood disorders and the availability of upgraded and sophisticated technologies. The ability to offer quick and fast results, which aids physicians in providing effective treatment for ailments, is projected to drive demand for hemoglobin testing systems over the projection period.
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
Mahendra Singh
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Source: Fact.MR